Ampulla of Vater Cancer
8
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
The Comparison of Miniinvasive and Open Pancreaticoduodenectomy for Cancer Pancreaticobiliary Zone
Duodenal Polyposis Classification in FAP
Efficacy and Safety of Endoscopic Papillectomy in the Treatment of Ampullary Neoplasms.
EUS Evaluation of CBD Diameter in Malignant Obstructive Jaundice
A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Direct Oral Anticoagulants for Cancer-associated Venous Thromboembolism
Enteral Nutrition After Pancreaticoduodenectomy
Comparison Between Internal and External Preoperative Biliary Drainage in Periampullary Cancers
Early Enteral Feeding After Pylorus Preserving Pancreatoduodenectomy